|
|
Article: Research and Markets: Growing Need for Pharmaceutical Companies in Psychiatry Sector to create Effective Patient Compliance Programs.
- Article from:
- Business Wire
- Article date:
- February 28, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c13218) has announced the addition of Stakeholder Insight: Patient Compliance in Psychiatry - From Patient Acquisition to Patient Retention to their offering
Generic saturation coupled with a poor R&D pipeline is forcing pharmaceutical companies to seek alternative ways of maintaining revenue growth in the ever-competitive psychiatry sector. Surprisingly, despite being long recognized as a costly problem, interest in patient compliance is only just gaining momentum and effective patient compliance programs have yet to become standard practice. Players in the schizophrenia, bipolar ...